Avenue Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Avenue Therapeutics (ATXI) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Avenue Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Avenue Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Avenue Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $7.5k | 46k | 0.16 |
| 2023-09-30 | $33k | 46k | 0.71 |